tiprankstipranks
LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
US Market
LBRX
LB Pharmaceuticals, Inc.
RESEARCH TOOLSreports

LB Pharmaceuticals, Inc. (LBRX) Financial Statements

Compare
42 Followers

LB Pharmaceuticals, Inc. Financial Overview

LB Pharmaceuticals, Inc.'s market cap is currently $683.61M. The company's EPS TTM is $; its P/E ratio is -22.34; LB Pharmaceuticals, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -321.00K$ 0.00$ 0.00$ 0.00
Operating Income$ -30.40M$ -64.83M$ -11.38M$ -2.81M
EBITDA$ -30.08M$ -63.01M$ -1.45M$ -12.19M
Net Income$ -25.20M$ -63.10M$ -6.28M$ -14.35M
Balance Sheet
Cash & Short-Term Investments$ 295.21M$ 28.00M$ 43.29M$ 21.40M
Total Assets$ 312.93M$ 33.53M$ 45.66M$ 21.49M
Total Debt$ 3.57M$ 3.70M$ 0.00$ 24.15M
Net Debt$ -246.60M$ -19.27M$ -14.98M$ 2.74M
Total Liabilities$ 11.62M$ 128.09M$ 80.13M$ 50.30M
Stockholders' Equity$ 301.31M$ -94.55M$ -34.47M$ -28.81M
Cash Flow
Free Cash Flow$ -35.26M$ -53.82M$ -12.12M$ -2.73M
Operating Cash Flow$ -35.21M$ -53.05M$ -12.09M$ -2.73M
Investing Cash Flow$ -39.89M$ 23.23M$ -28.01M$ 123.00K
Financing Cash Flow$ 302.56M$ 38.31M$ 33.68M$ 22.96M
Currency in USD

LB Pharmaceuticals, Inc. Earnings and Revenue History

Income Statement >

LB Pharmaceuticals, Inc. Debt to Assets

Balance Sheet >

LB Pharmaceuticals, Inc. Cash Flow

Cash Flow >

LB Pharmaceuticals, Inc. Forecast EPS vs Actual EPS

Earnings >